Savaria stock has November 4 results date and P/ E 24.38

Published on 10/17/2026 at 21:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Income hit CAD 68.80 million in first-half 2026. Savaria stock cost CAD 29.50 on October 16, 2026, down 0.34 percent versus Toronto's prior close.

Results date shapes the calendar

Savaria's next results release is scheduled for November 4, 2026.
Operating income reached CAD 68.80 million in the first half of 2026, up 43.50 percent year over year.
Savaria stock was last at CAD 29.50 on October 16, 2026 at 4:00 p.m. ET on the TSX, down 0.34 percent versus the prior close.
Savaria had a P/E ratio of 24.38 and a market capitalization of CAD 2.1 billion as of October 16, 2026.

SIS, CA8051121090, Illustration mit AI erstellt.

Savaria Corporation (ISIN CA8051121090) will publish its third-quarter 2026 results on November 4, 2026, followed by an investor call on November 5, according to the company's investor information. The next reporting date gives the stock a clear calendar marker after its latest half-year figures. Savaria was last at CAD 29.50 on October 16, 2026 at 4:00 p.m. ET on the TSX, down 0.34 percent versus the prior close.

First-half operating income rose

The company generated CAD 68.80 million in operating income during the first half of 2026, an increase of 43.50 percent from the same period of 2025. Revenue reached CAD 481.30 million, up 7.70 percent year over year, while the operating margin rose to 14.30 percent from 10.70 percent, according to Savaria's second-quarter report.

Stock sits below its yearly high

At CAD 29.50, the stock stood 7.67 percent below its 52-week high of CAD 31.95 and CAD 8.78 above its 52-week low of CAD 20.72 on October 16, 2026. The trading range places the latest Toronto quotation nearer the upper end of its annual band than the lower end.

The valuation snapshot was CAD 2.1 billion in market capitalization and a price-to-earnings ratio of 24.38 as of October 16, 2026. The trailing dividend yield was 2.00 percent, with the company maintaining a monthly distribution policy.

Comparison with peers

Savaria: minus 0.34 percent, P/E 24.38, market capitalization CAD 2.1 billion.

WELL Health Technologies (TSX, CAD): minus 1.90 percent, P/E 164.14, market capitalization CAD 1.1 billion.

Cameco (TSX, CAD): minus 2.39 percent, P/E 141.02, market capitalization CAD 50.2 billion.

Next date for investors

The next scheduled event is the third-quarter results release on November 4, 2026, followed by the investor call on November 5, 2026. The dates place the next material company update within the coming reporting cycle.